h1

h2

h3

h4

h5
h6


001     777746
005     20230209042440.0
024 7 _ |a G:(EU-Grant)841956
|d 841956
|2 CORDIS
024 7 _ |a G:(EU-Call)H2020-MSCA-IF-2018
|d H2020-MSCA-IF-2018
|2 CORDIS
024 7 _ |a corda__h2020::841956
|2 originalID
035 _ _ |a G:(EU-Grant)841956
150 _ _ |a De novo design of an UpConverting metalloProtein
|y 2019-09-02 - 2021-09-01
371 _ _ |a University of Birmingham
|b University of Birmingham
|d United Kingdom
|e http://www.birmingham.ac.uk/index.aspx
|v CORDIS
372 _ _ |a H2020-MSCA-IF-2018
|s 2019-09-02
|t 2021-09-01
450 _ _ |a UCLnProt
|w d
|y 2019-09-02 - 2021-09-01
510 1 _ |0 I:(DE-588b)5098525-5
|a European Union
|2 CORDIS
680 _ _ |a Herein, we propose to design de novo (“from scratch”) the first upconverting metalloprotein. This will be achieved by exploiting a new class of lanthanide coiled coils (LCC), to generate bimetallic derivatives. These will, for the first time, combine the attractive photophysical properties of Ln complexes, with de novo designed coiled coil scaffolds capable of selectively binding different Ln ions at well-defined and tuneable distances. This programme of work will provide a new strategy for unlocking the full potential of science at the interface of biology and inorganic chemistry, by combining previously unexplored ligands with traditional inorganic complexes, for applications beyond those offered by biology, such as upconversion. The complementary expertise of Dr Borghesani (bioinorganic chemistry and spectroscopy) and the supervisor Dr Peacock (metallopeptide design) offer the unique combination to realise the full potential of multimetallic LCCs, and will, in conjunction with two planned short secondments, provide Dr Borghesani with new and cutting-edge research training.
909 C O |o oai:juser.fz-juelich.de:870094
|p authority:GRANT
|p authority
909 C O |o oai:juser.fz-juelich.de:870094
970 _ _ |a oai:dnet:corda__h2020::d2436da5c10144e3cc9db3aec32f9dfd
980 _ _ |a G
980 _ _ |a CORDIS
980 _ _ |a AUTHORITY


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21